Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2017

  • ID: 4394488
  • Report
  • 130 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Akers Biosciences Inc
  • Binghamton University
  • ChipCare Corp
  • McKesson Corp
  • OncoGenesis
  • Radisens Diagnostics Ltd
  • MORE
Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2017

Summary

The Medical Devices sector report, “Point-of-Care (POC) Analyzers - Medical Devices Pipeline Assessment, 2017" provides an overview of Point-of-Care (POC) Analyzers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Point-of-Care (POC) Analyzers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Point-of-Care (POC) Analyzers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Point-of-Care (POC) Analyzers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Point-of-Care (POC) Analyzers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Akers Biosciences Inc
  • Binghamton University
  • ChipCare Corp
  • McKesson Corp
  • OncoGenesis
  • Radisens Diagnostics Ltd
  • MORE
1 Table of Contents
2 Introduction
2.1 Point-of-Care (POC) Analyzers Overview
3 Products under Development
3.1 Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development
3.2 Point-of-Care (POC) Analyzers - Pipeline Products by Territory
3.3 Point-of-Care (POC) Analyzers - Pipeline Products by Regulatory Path
3.4 Point-of-Care (POC) Analyzers - Pipeline Products by Estimated Approval Date
3.5 Point-of-Care (POC) Analyzers - Ongoing Clinical Trials
4 Point-of-Care (POC) Analyzers - Pipeline Products under Development by Companies
4.1 Point-of-Care (POC) Analyzers Companies - Pipeline Products by Stage of Development
4.2 Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development
5 Point-of-Care (POC) Analyzers Companies and Product Overview
5.1 Akers Biosciences Inc Company Overview
5.1.1 Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 Akonni Biosystems Inc Company Overview
5.2.1 Akonni Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Alere Inc Company Overview
5.3.1 Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 Amplino B.V. Company Overview
5.4.1 Amplino B.V. Pipeline Products & Ongoing Clinical Trials Overview
5.5 Analytical Diagnostic Solutions Inc Company Overview
5.5.1 Analytical Diagnostic Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 ApoCell Inc Company Overview
5.6.1 ApoCell Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 Aquila Diagnostic Systems Inc. Company Overview
5.7.1 Aquila Diagnostic Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.8 Atonomics A/S Company Overview
5.8.1 Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview
5.9 Attophotonics Biosciences GmbH Company Overview
5.9.1 Attophotonics Biosciences GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.10 Beckman Coulter Inc Company Overview
5.10.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
5.11 Binghamton University Company Overview
5.11.1 Binghamton University Pipeline Products & Ongoing Clinical Trials Overview
5.12 Bio-Alternative Medical Devices Ltd Company Overview
5.12.1 Bio-Alternative Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.13 BioMedomics Inc Company Overview
5.13.1 BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 bioMerieux S.A. Company Overview
5.14.1 bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview
5.15 Biopico Systems Inc. Company Overview
5.15.1 Biopico Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.16 Boston University Company Overview
5.16.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview
5.17 CardioGenics Inc Company Overview
5.17.1 CardioGenics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.18 Cepheid Company Overview
5.18.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview
5.19 ChipCare Corp Company Overview
5.19.1 ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview
5.20 City, University of London Company Overview
5.20.1 City, University of London Pipeline Products & Ongoing Clinical Trials Overview
5.21 Co-Diagnostics HBDC, Inc. Company Overview
5.21.1 Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.22 Exosome Diagnostics Inc Company Overview
5.22.1 Exosome Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.23 Florida International University Company Overview
5.23.1 Florida International University Pipeline Products & Ongoing Clinical Trials Overview
5.24 Indian Institute of Technology Madras Company Overview
5.24.1 Indian Institute of Technology Madras Pipeline Products & Ongoing Clinical Trials Overview
5.25 Indiana University Company Overview
5.25.1 Indiana University Pipeline Products & Ongoing Clinical Trials Overview
5.26 Magna Diagnostics GmbH Company Overview
5.26.1 Magna Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.27 Maxygen-mobile DNA tests Company Overview
5.27.1 Maxygen-mobile DNA tests Pipeline Products & Ongoing Clinical Trials Overview
5.28 mBio Diagnostics Inc Company Overview
5.28.1 mBio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.29 McKesson Corp Company Overview
5.29.1 McKesson Corp Pipeline Products & Ongoing Clinical Trials Overview
5.30 MML Ltd Company Overview
5.30.1 MML Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.31 Molbio Diagnostics Pvt. Ltd. Company Overview
5.31.1 Molbio Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.32 Molecular Warehouse Ltd Company Overview
5.32.1 Molecular Warehouse Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.33 Mologic Ltd Company Overview
5.33.1 Mologic Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.34 Nalia Systems Ltd Company Overview
5.34.1 Nalia Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.35 Newcastle University Company Overview
5.35.1 Newcastle University Pipeline Products & Ongoing Clinical Trials Overview
5.36 Ohmx Corp Company Overview
5.36.1 Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview
5.37 OncoGenesis Company Overview
5.37.1 OncoGenesis Pipeline Products & Ongoing Clinical Trials Overview
5.38 Pacific Nanoscience, Inc. Company Overview
5.38.1 Pacific Nanoscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.39 Parallax Health Sciences, Inc. Company Overview
5.39.1 Parallax Health Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.40 Phoenix Biosystems Inc Company Overview
5.40.1 Phoenix Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview
5.41 POC Medical Systems Inc. Company Overview
5.41.1 POC Medical Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.42 Pocared Diagnostics Ltd. Company Overview
5.42.1 Pocared Diagnostics Ltd. Pipeline Products & Ongoing Clinical Trials Overview
5.43 PositiveID Corp Company Overview
5.43.1 PositiveID Corp Pipeline Products & Ongoing Clinical Trials Overview
5.44 Quanterix Corp Company Overview
5.44.1 Quanterix Corp Pipeline Products & Ongoing Clinical Trials Overview
5.45 Radisens Diagnostics Ltd Company Overview
5.45.1 Radisens Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.46 SenGenix Inc Company Overview
5.46.1 SenGenix Inc Pipeline Products & Ongoing Clinical Trials Overview
5.47 Thermal Gradient Inc Company Overview
5.47.1 Thermal Gradient Inc Pipeline Products & Ongoing Clinical Trials Overview
5.48 Trinity Biotech Plc Company Overview
5.48.1 Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview
5.49 Two Pore Guys Inc Company Overview
5.49.1 Two Pore Guys Inc Pipeline Products & Ongoing Clinical Trials Overview
5.50 University of California Berkeley Company Overview
5.50.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview
5.51 ViroCyt Inc Company Overview
5.51.1 ViroCyt Inc Pipeline Products & Ongoing Clinical Trials Overview
5.52 Wellstat Diagnostics LLC Company Overview
5.52.1 Wellstat Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
6 Point-of-Care (POC) Analyzers- Recent Developments
6.1 Aug 30, 2017: PositiveID’s ExcitePCR Subsidiary Announces FireflyDX-Portable: A Lightweight, Bookbag-sized, Realtime Pathogen Detection System, with Commercial Availability Slated for Summer 2018
6.2 Aug 30, 2017: bioMerieux - First-Half 2017 Results
6.3 Aug 16, 2017: Two Pore Guys Announces Positive Results from Pilot Point-of-Care Liquid Biopsy Study with UCSF
6.4 Aug 08, 2017: PositiveID Successfully Detects Ebola Virus on its Firefly Dx Prototype System
6.5 Jul 27, 2017: McKesson Reports Fiscal 2018 First-Quarter Results
6.6 Jul 20, 2017: bioMerieux - Second-Quarter 2017 Business Review
6.7 Jul 18, 2017: Quanterix Boosts Investments in its Accelerator Lab to Support Rapid Growth of Simoa Technology
6.8 Jul 18, 2017: Quanterix, Partners Develop PCR-free miRNA Detection Method for Liver Toxicity Testing
6.9 Jun 21, 2017: Diabetes Research Unit Cymru confirms EKF POCT HbA1c testing comparable to lab-based HPLC
6.10 Jun 15, 2017: Zenosense: Issuance of U.S. MIDS Patent
6.11 May 31, 2017: Exosome Diagnostics Will Demonstrate the “Shahky” Point of Care Protein Detection Instrument at American Society for Clinical Oncology
6.12 May 24, 2017: PositiveID Forms ExcitePCR Subsidiary to Better Position its Firefly Dx System for $19 Billion Global Point-of-Care Diagnostics Market
6.13 May 18, 2017: McKesson Reports Fiscal 2017 Fourth-Quarter and Full-Year Results
6.14 Apr 20, 2017: bioMerieux - First-Quarter 2017 Business Review
6.15 Mar 02, 2017: McKesson Provides Financial Update to Reflect Creation of a New Healthcare Information Technology Company
6.16 Feb 16, 2017: New study reaffirms Quo-Test A1c meets IFCC performance criteria
6.17 Feb 03, 2017: Exosome Diagnostics Announces Early Access Program for “Shahky” - Exosome Protein Interrogation Instrument
6.18 Jan 26, 2017: Vantage Oncology’s 50 Centers and More Than 350 Affiliated Physicians Join The US Oncology Network
6.19 Jan 25, 2017: McKesson Reports Fiscal 2017 Third-Quarter Results
6.20 Jan 23, 2017: Zenosense: New Patent Application for Additional MIDS Detection Method
6.21 Jan 19, 2017: bioMerieux - Fourth-Quarter 2016 Business Review
6.22 Jan 17, 2017: McKesson Finalizes Settlement with U.S. Department of Justice and U.S. Drug Enforcement Administration to Resolve Past Claims
6.23 Jan 11, 2017: GenePOC Announces CE Marking for its Revogene Instrument
6.24 Jan 05, 2017: McKesson and Change Healthcare Announce New Company Will Be Named Change Healthcare
6.25 Jan 04, 2017: Exosome Diagnostics Runs World's First Point of Care Liquid Biopsy Instrument Within Leading Boston Hospital
6.26 Dec 28, 2016: McKesson Completes Acquisition of Rexall Health and Appoints Domenic Pilla as CEO of McKesson Canada
6.27 Dec 21, 2016: McKesson and Change Healthcare Announce Termination off Hart-Scott-Rodino Act Waiting Period for the Creation of a New Healthcare Information Technology Company
6.28 Dec 08, 2016: Exosome Diagnostics Announces the First Instrument for Point of Care Liquid Biopsy
6.29 Nov 29, 2016: Beckman Coulter announces significant investment in UK microbiology market with DxN VERIS Molecular Diagnostics System
6.30 Nov 15, 2016: PositiveID to Exhibit Firefly Dx System at the AMSUS Federal Health 2016 Conference
6.31 Nov 07, 2016: Pierre Boulud appointed Corporate Vice Presidentof the Asia Pacific region at bioMerieux
6.32 Oct 31, 2016: Zenosense MIDS Cardiac Bench Reader Development
6.33 Oct 27, 2016: McKesson Reports Fiscal 2017 Second-Quarter Results and Revised Fiscal 2017 Outlook
6.34 Oct 24, 2016: McKesson Releases Fiscal 2016 Corporate Social Responsibility Report
6.35 Oct 20, 2016: ViroCyt Develops Rapid Detection System For Enterovirus 71
6.36 Oct 20, 2016: bioMerieux-Business Review for the nine months ended September 30, 2016
6.37 Oct 04, 2016: Trinity Biotech Announces FDA 510(k) Submission withdrawal for Meritas Point of Care Analyzer
6.38 Sep 19, 2016: Zenosense General Update - Cardiac Device Development
7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development
Table 2: Point-of-Care (POC) Analyzers - Pipeline Products by Territory
Table 3: Point-of-Care (POC) Analyzers - Pipeline Products by Regulatory Path
Table 4: Point-of-Care (POC) Analyzers - Pipeline Products by Estimated Approval Date
Table 5: Point-of-Care (POC) Analyzers - Ongoing Clinical Trials
Table 6: Point-of-Care (POC) Analyzers Companies - Pipeline Products by Stage of Development
Table 7: Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development
Table 8: Akers Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: minDNAnalyzer - Product Status
Table 10: minDNAnalyzer - Product Description
Table 11: Akonni Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 12: TruDx 2000 Platform - Product Status
Table 13: TruDx 2000 Platform - Product Description
Table 14: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Clondiag HIV Molecular Device - Product Status
Table 16: Clondiag HIV Molecular Device - Product Description
Table 17: Amplino B.V. Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Scout PCR Analyzer - Product Status
Table 19: Scout PCR Analyzer - Product Description
Table 20: Analytical Diagnostic Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 21: POC Device - Malaria - Product Status
Table 22: POC Device - Malaria - Product Description
Table 23: ApoCell Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: ApoStream System - Product Status
Table 25: ApoStream System - Product Description
Table 26: Aquila Diagnostic Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Accutas Malaria Diagnostic System - Product Status
Table 28: Accutas Malaria Diagnostic System - Product Description
Table 29: Atonomics A/S Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Atolyzer PoC - Product Status
Table 31: Atolyzer PoC - Product Description
Table 32: Attophotonics Biosciences GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Nanoparticle Microfluidic Color Device - Product Status
Table 34: Nanoparticle Microfluidic Color Device - Product Description
Table 35: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 36: DxN VERIS MDx System - Product Status
Table 37: DxN VERIS MDx System - Product Description
Table 38: Binghamton University Pipeline Products & Ongoing Clinical Trials Overview
Table 39: U-PAC - Product Status
Table 40: U-PAC - Product Description
Table 41: Bio-Alternative Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 42: Magnetic Immunoassay Detection System - Product Status
Table 43: Magnetic Immunoassay Detection System - Product Description
Table 44: BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 45: Next Generation Ultra-sensitive Nanotube Platform - Product Status
Table 46: Next Generation Ultra-sensitive Nanotube Platform - Product Description
Table 47: TR-LFIA Diagnostic Platform - Product Status
Table 48: TR-LFIA Diagnostic Platform - Product Description
Table 49: bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Magnotech System - Product Status
Table 51: Magnotech System - Product Description
Table 52: Biopico Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 53: MONITOR System - Product Status
Table 54: MONITOR System - Product Description
Table 55: Boston University Pipeline Products & Ongoing Clinical Trials Overview
Table 56: Molecular Diagnostic Device - Sexually Transmitted Infections - Product Status
Table 57: Molecular Diagnostic Device - Sexually Transmitted Infections - Product Description
Table 58: Point-Of-Care Device - Allergen-Specific IgE - Product Status
Table 59: Point-Of-Care Device - Allergen-Specific IgE - Product Description
Table 60: CardioGenics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 61: QL Care Analyzer - Product Status
Table 62: QL Care Analyzer - Product Description
Table 63: Cepheid Pipeline Products & Ongoing Clinical Trials Overview
Table 64: GeneXpert Omni - Product Status
Table 65: GeneXpert Omni - Product Description
Table 66: GeneXpert Omni CLIA-Waived Point-of-Care System - Product Status
Table 67: GeneXpert Omni CLIA-Waived Point-of-Care System - Product Description
Table 68: Cepheid - Ongoing Clinical Trials Overview
Table 69: GeneXpert Omni - Xpert Omni Performance Evaluation for Linkage to Tuberculosis Care: The XPEL TB Trial
Table 70: ChipCare Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 71: Polyvalent Analyzer (PAx) - Product Status
Table 72: Polyvalent Analyzer (PAx) - Product Description
Table 73: City, University of London Pipeline Products & Ongoing Clinical Trials Overview
Table 74: POC Device - Mood Disorders - Product Status
Table 75: POC Device - Mood Disorders - Product Description
Table 76: Co-Diagnostics HBDC, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 77: LightPCR - Product Status
Table 78: LightPCR - Product Description
Table 79: Exosome Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 80: Shahky - Product Status
Table 81: Shahky - Product Description
Table 82: Florida International University Pipeline Products & Ongoing Clinical Trials Overview
Table 83: Cortisol Detector - Product Status
Table 84: Cortisol Detector - Product Description
Table 85: Indian Institute of Technology Madras Pipeline Products & Ongoing Clinical Trials Overview
Table 86: Microfluidic Flow Analyzer - Product Status
Table 87: Microfluidic Flow Analyzer - Product Description
Table 88: Indiana University Pipeline Products & Ongoing Clinical Trials Overview
Table 89: Microfluidic Device - Cancer - Product Status
Table 90: Microfluidic Device - Cancer - Product Description
Table 91: Magna Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 92: MAZER System - Product Status
Table 93: MAZER System - Product Description
Table 94: Maxygen-mobile DNA tests Pipeline Products & Ongoing Clinical Trials Overview
Table 95: Maxygen POC Device - Product Status
Table 96: Maxygen POC Device - Product Description
Table 97: mBio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 98: MBio CD4 System - Product Status
Table 99: MBio CD4 System - Product Description
Table 100: McKesson Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 101: Proventys PDx System - Product Status
Table 102: Proventys PDx System - Product Description
Table 103: MML Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 104: MIDS Cardiac - Product Status
Table 105: MIDS Cardiac - Product Description
Table 106: Molbio Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 107: Truelab Quattro Analyzer - Product Status
Table 108: Truelab Quattro Analyzer - Product Description
Table 109: Molecular Warehouse Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 110: Portable Biosensor Device - Product Status
Table 111: Portable Biosensor Device - Product Description
Table 112: Mologic Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 113: ACuTEGA - Product Status
Table 114: ACuTEGA - Product Description
Table 115: Nalia Systems Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 116: NALIA Single-Patient Point-Of-Care Device - Product Status
Table 117: NALIA Single-Patient Point-Of-Care Device - Product Description
Table 118: Newcastle University Pipeline Products & Ongoing Clinical Trials Overview
Table 119: SmartHEALTH POC System - Colorectal Cancer - Product Status
Table 120: SmartHEALTH POC System - Colorectal Cancer - Product Description
Table 121: Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 122: Handheld Clinical Analyzer - Product Status
Table 123: Handheld Clinical Analyzer - Product Description
Table 124: OncoGenesis Pipeline Products & Ongoing Clinical Trials Overview
Table 125: Genesis Point-Of-Care Diagnostic System - Product Status
Table 126: Genesis Point-Of-Care Diagnostic System - Product Description
Table 127: Pacific Nanoscience, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 128: Nanomonitor - Product Status
Table 129: Nanomonitor - Product Description
Table 130: Parallax Health Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 131: SPARKS Mobile - Product Status
Table 132: SPARKS Mobile - Product Description
Table 133: Phoenix Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 134: Point of Care HIV Combo Device - Product Status
Table 135: Point of Care HIV Combo Device - Product Description
Table 136: POC Medical Systems Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 137: Pandora CDx Point-of-Care System - Product Status
Table 138: Pandora CDx Point-of-Care System - Product Description
Table 139: Pocared Diagnostics Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 140: POCARED P-1000 - Product Status
Table 141: POCARED P-1000 - Product Description
Table 142: PositiveID Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 143: Firefly Dx System - Product Status
Table 144: Firefly Dx System - Product Description
Table 145: Firefly Dx System - Zika Virus - Product Status
Table 146: Firefly Dx System - Zika Virus - Product Description
Table 147: Quanterix Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 148: Simoa 5.0 - Product Status
Table 149: Simoa 5.0 - Product Description
Table 150: Radisens Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 151: Radisens Instrument - Product Status
Table 152: Radisens Instrument - Product Description
Table 153: SenGenix Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 154: SenGenix Strips And Reader System - Product Status
Table 155: SenGenix Strips And Reader System - Product Description
Table 156: Thermal Gradient Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 157: FlashDirect-HC - Product Status
Table 158: FlashDirect-HC - Product Description
Table 159: FlashDirect-LC - Product Status
Table 160: FlashDirect-LC - Product Description
Table 161: Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 162: Meritas Point of Care Analyzer - Product Status
Table 163: Meritas Point of Care Analyzer - Product Description
Table 164: Two Pore Guys Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 165: Handheld Nanopore Based Device - Cancer - Product Status
Table 166: Handheld Nanopore Based Device - Cancer - Product Description
Table 167: University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview
Table 168: Microfluidic Blotting Device - Product Status
Table 169: Microfluidic Blotting Device - Product Description
Table 170: Mobile Molecular Diagnostics System - Product Status
Table 171: Mobile Molecular Diagnostics System - Product Description
Table 172: Multi-dimensional Microfluidic Device - Product Status
Table 173: Multi-dimensional Microfluidic Device - Product Description
Table 174: Point-Of-Care Microfluidic Device - Acute Promyelocytic Leukemia - Product Status
Table 175: Point-Of-Care Microfluidic Device - Acute Promyelocytic Leukemia - Product Description
Table 176: ViroCyt Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 177: ViroTag EV71 - Product Status
Table 178: ViroTag EV71 - Product Description
Table 179: Wellstat Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 180: Electrochemiluminescent Based RNA Detection Platform - Product Status
Table 181: Electrochemiluminescent Based RNA Detection Platform - Product Description
Table 182: Glossary

List of Figures
Figure 1: Point-of-Care (POC) Analyzers - Pipeline Products by Stage of Development
Figure 2: Point-of-Care (POC) Analyzers - Pipeline Products by Territory
Figure 3: Point-of-Care (POC) Analyzers - Pipeline Products by Regulatory Path
Figure 4: Point-of-Care (POC) Analyzers - Pipeline Products by Estimated Approval Date
Figure 5: Point-of-Care (POC) Analyzers - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Akers Biosciences Inc
  • Akonni Biosystems Inc
  • Alere Inc
  • Amplino B.V.
  • Analytical Diagnostic Solutions Inc
  • ApoCell Inc
  • Aquila Diagnostic Systems Inc.
  • Atonomics A/S
  • Attophotonics Biosciences GmbH
  • Beckman Coulter Inc
  • Binghamton University
  • Bio-Alternative Medical Devices Ltd
  • BioMedomics Inc
  • bioMerieux S.A.
  • Biopico Systems Inc.
  • Boston University
  • CardioGenics Inc
  • Cepheid
  • ChipCare Corp
  • City, University of London
  • Co-Diagnostics HBDC, Inc.
  • Exosome Diagnostics Inc
  • Florida International University
  • Indian Institute of Technology Madras
  • Indiana University
  • Magna Diagnostics GmbH
  • Maxygen-mobile DNA tests
  • mBio Diagnostics Inc
  • McKesson Corp
  • MML Ltd
  • Molbio Diagnostics Pvt. Ltd.
  • Molecular Warehouse Ltd
  • Mologic Ltd
  • Nalia Systems Ltd
  • Newcastle University
  • Ohmx Corp
  • OncoGenesis
  • Pacific Nanoscience, Inc.
  • Parallax Health Sciences, Inc.
  • Phoenix Biosystems Inc
  • POC Medical Systems Inc.
  • Pocared Diagnostics Ltd.
  • PositiveID Corp
  • Quanterix Corp
  • Radisens Diagnostics Ltd
  • SenGenix Inc
  • Thermal Gradient Inc
  • Trinity Biotech Plc
  • Two Pore Guys Inc
  • University of California Berkeley
  • ViroCyt Inc
  • Wellstat Diagnostics LLC
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll